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Apresentamos o caso de um hematoma 
subdural atraumático num feto de 35 semanas 
de gestação, cuja mãe se encontrava sob 
terapêutica anticoagulante com acenocumarol, 
devido a prótese mitral mecânica. A ecografia, 
realizada às 35 semanas de gestação por redução 
dos movimentos fetais, revelou aumento do 
espaço incracraniano extracerebral e provável 
malformação cortical. RM fetal efetuada 
no dia seguinte revelou extenso hematoma 
subdural hemisférico bilateral, com sinais 
de atividade e significativo efeito de massa. 
Ecografia de controlo detetou ausência de 
batimentos cardíacos fetais e autópsia confimou 
o diagnóstico. Tanto quanto nos foi possível 
averiguar, este é o mais extenso caso de HSD 
fetal relacionado com a toma de acenocoumarol 
descrito em RM fetal e um exelente exemplo da 
utilidade dets técnica no diagnóstico pré-natal de 
lesões hemorrágicas.
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Abstract
Fetal intracranial hemorrhages are typical of  
the germinal matrix, associated with fetal or 
placental problems. Subdural hemorrhages in 
utero are extremely rare but have been reported 
in coagulation disorders or maternal trauma. We 
present a case of  atraumatic subdural hematoma 
in a 35 gestational week fetus, whose mother was 
under oral anticoagulation for prosthetic mitral 
valve. The mother complained of  reduced fetal 
movement and ultrasound was inconclusive. 
Fetal magnetic resonance imaging (MRI) was 
performed the following day. MRI revealed an 
extensive subdural hematoma involving both 
hemispheric convexities and the tentorium, with 
significant mass effect. No heartbeat was detected 
in an US performed 1 day after MRI. Autopsy 
confirmed the diagnosis. To our knowledge it 
is the most extensive acenocoumarol-related in-
utero SDH reported, and an excellent example of  
how fetal MRI might aid in prenatal diagnosis of  
fetal hemorrhagic complications.
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Caso Clínico / Radiological Case Report
Introduction
Subdural hematoma (SDH) is a frequent finding in newborns, 
usually occurring during traumatic vaginal delivery. On the 
other hand, antenatal SDH is exceptional.1 It may occur 
spontaneously or in association with various maternal or fetal 
conditions including trauma, coagulopathies, intrauterine 
infections and iatrogenic effect of  maternal drug intake.2 
Vitamin K antagonists cross the placental barrier and are 
associated with coumarin embryopathy, characterized by nasal 
hypoplasia and/or stippled epiphyses, when exposure occurs 
in the first trimester, while exposure in the second or third 
trimesters is associated with central nervous system (CNS) 
malformations or hemorrhagic complications.3,4 
We present a rare case of  extensive, acenocoumarol-associated, 
subdural hematoma occurring in the third trimester, 
emphasizing the importance of  anticoagulation as a cause of  
antenatal intracranial bleeding and the major role played by 
fetal magnetic resonance imaging (MRI) in diagnosing fetal 
hemorrhagic.
Case Report
A 24-year-old woman under life-long oral anticoagulation 
after mitral valve replacement at the age of  13, due 
to rheumatic valve disease, presented to her attending 
physician with a six weeks and four days pregnancy. She 
had 3 previous failed pregnancies: the first was complicated 
by warfarin embryopathy and medically interrupted at 24 
weeks of  gestation; the following two gestations resulted in 
spontaneous abortions at 9 and 16 weeks, without known 
cause and no clear fetal anomalies at pathological analysis. 
She also suffered deep vein thrombosis (DVT) of  the left 
leg during the 2nd pregnancy (at 10 weeks of  gestation), 
while under treatment with enoxaparin (60 mg twice daily) 
and mechanic valve thrombosis at the age of  16, with need 
for emergency prosthesis replacement.
Due to the high risk and history of  thrombotic events 
it was decided to maintain therapy with acenocoumarol 
(4 mg daily) throughout the gestation. International 
Normalization Ratio (INR) values were measured every 15 
days (kept between 2,3 and 3,2) and fetal ultrasound (US) 
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scans performed every 2-3 weeks. There was no evidence of  
intracranial abnormalities, fetal or maternal bleeding.
At 35 weeks of  gestation, routine US scan showed enlargement 
of  the extracerebral space with abnormal morphology 
of  the cerebral convexities, suggesting a simplified gyral 
pattern. Fetal MRI, performed the following day, revealed 
extensive bilateral subdural collections, involving cerebral 
convexities and extending to the tentorium. They presented 
heterogeneous signal (Fig. 1) mainly hyperintense on T2 
weighted images (WI) and “blooming” on gradient-echo 
T2*WI (Fig. 2), but with areas of  mixed low and high T2 
signal (primarily on the right side), suggesting hemorrhagic 
collections with signs of  active bleeding (Fig.1). The SDH 
had right side predominance and significant mass effect: 
generalized effacement of  cerebral sulci, cisternal spaces and 
right lateral ventricle, midline shift to the left and cerebellar 
amygdalae herniation. It was not possible to identify any 
cortical malformations due to distortion of  encephalic 
parenchyma.  
Acenocoumarol was immediately discontinued and replaced 
with enoxaparin, but one day later US confirmed fetal death.
Pathological study confirmed the presence of  moderate 
intracranial SDH, with small subarachnoid hematic 
component in the posterior fossa. Hemorrhagic foci of  the 
thymus gland were also identified.  No malformations of  the 
CNS nor were associated skeletal anomalies identified. 
Discussion
The fatal antenatal SDH presented was most presumed 
secondary to anticoagulant exposure, given the maternal 
history of  acenocoumarol intake (INR at admission: 2,9), 
the lack of  other predisposing factors, and the absence of  
abnormal findings in the previous US scans. The decision 
to maintain anticoagulation throughout pregnancy was based 
on maternal history of  serious thrombotic events (DVT and 
valve thrombosis), one of  which occurred during a previous 
gestation. 
Anticoagulation during pregnancy is a known is risk factor 
for both mother and fetus.  Vitamin K antagonists cross 
the placenta and increase risk of  spontaneous abortion, 
embryopathy and fetal hemorrhage,4 and although heparin 
does not cross the placental barrier, it considerably increases 
the thrombotic risk for the mother3. The use of  coumarins 
throughout pregnancy can be justified if  the risk of  maternal 
thrombotic events outweighs the risk of  fetal complications, 
with a known incidence of  hemorrhage of  2.5% (80% 
occurring at delivery) and the incidence of  valve thrombosis 
approximately 4% (higher if  heparin is used).3,5
On US, diagnosis of  SDH is often difficult and asymptomatic 
enlargement of  the cranial dimensions may be the only 
finding.  In our case US findings were nonspecific and a 
cortical malformation suspected, due to the loss of  the 
normal external cerebral architecture. With the advent of  
ultrafast MRI techniques, it is now possible to obtain clear 
images of  the fetus and this imaging method proved essential 
to our diagnosis as it provided a clear image of  the location 
and extent of  the hemorrhage and its secondary effects. 
Conclusion
Anticoagulant-associated fetal hemorrhage is a rare but 
severe event. Unfortunately, there is no alternative regimen 
that can effectively replace vitamin K antagonists in women 
with mechanical heart valves during late pregnancy. Although 
US studies are valuable for regular monitoring of  fetal 
hemorrhagic complications, in suspicious cases MRI offers a 
more detailed assessment of  fetal CNS and provides a better 
characterization of  both hemorrhagic and malformative 
pathology.Figure 1 – Fetal MRI. 35-week-old fetus. Coronal (a), sagittal (b) and axial 
(c, d) T2WI. Subdural hematoma and loss of  differentiation of  of  cerebral 
parenchyma. The SDH is hypointense with area of  mixed signal (white 
arrow) on the right, suggesting active bleeding. There is herniation of  the 
amygdalae (black arrow)
Figure 2 – Axial GET2*WI (a,b) and 
T1WI (c). The subdural hematoma 
shows “blooming” on T2* and extends 
into the tentorium on the right (white 
arrow) is slightly hyperintense on T1WI.
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